HLA-A30
From Wikipedia, the free encyclopedia
|
major histocompatibility complex (human), class I, A30
|
||
| Alleles | A*3001 A*3002 A*3003 A*3004 |
|
| Structure (See HLA-A) | ||
| Identifiers |
3001 3002 3003 3004
|
|
| Symbol(s) | HLA-A | |
| EBI-HLA | A*3001 | |
| EBI-HLA | A*3002 | |
| EBI-HLA | A*3003 | |
| EBI-HLA | A*3004 | |
| Shared data | ||
| Locus | chr.6 6p21.31 | |
HLA-A30 (A30) is an HLA-A serotype. The serotype identifies the more common HLA-A*30 gene products. A30 is a split antigen of the A19 broad antigen serotype group. It is similar to the A29, A31, A32, A33, and A74 HLA antigens.
[edit] Serotype
| A*30 | A30 | A19 | Sample |
| allele | % | % | size (N) |
| 3001 | 89 | 1 | 2895 |
| 3002 | 93 | 1 | 2124 |
| 3003 | 67 | 6 | |
| 3004 | 94 | 85 |
[edit] Disease association
A*3002 alters Type 1 diabetes risk[2]
[edit] References
- ^ derived from IMGT/HLA
- ^ Noble J, Valdes A, Bugawan T, Apple R, Thomson G, Erlich H (2002). "The HLA class I A locus affects susceptibility to type 1 diabetes.". Hum Immunol 63 (8): 657–64. doi:. PMID 12121673.
|
|||||

